The purpose of this study was to construct a multidimensional self-administered qualityof life
questionnaire specific to prostate cancer within the EORTC framework and to test its …

Abstract Objectives The EORTC Quality of Life (QL) Group has developed a questionnaire,
the EORTC QLQ-PR25, for evaluating QL in prostate cancer. The aim of this study is to …

Objective To assess the quality of life (QoL) of patients with localized prostate cancer (LPC)
after treatment by radical radiotherapy (RR). Patients and methods An 'ad hoc'self …

Purpose: To assess morbidity, side effects, and quality of life (QoL) in patients treated for
localized prostate cancer with curative aim. Methods and Materials: This descriptive cross …

Purpose: To report long-term outcomes in terms of health-related quality of life (HRQoL) and
survival of a dose-escalating radiotherapy protocol and to validate a new disease-specific …

BACKGROUND Treatment of localized prostate carcinoma (LPC) using radiotherapy (RT)
can induce disturbances in a patient's quality of life (QOL) and urinary and intestinal …

Objective: The EORTC Quality of Life Group has developed a questionnaire for evaluating
Quality of Life in international clinical trials: EORTC QLQ-C30, which is widely used in many …

Objectives. To develop a psychometrically valid and clinically useful questionnaire to assess
health-related quality of life (HRQOL) in patients with prostate cancer (PCa) undergoing …

Quality of life (QoL) is now commonly studied in prostate cancer. However, little is known
about the appropriateness of the various QoL instruments in this group of patients. The …

Background To evaluate quality of life (QoL) 10 years after treatments for localised prostate
cancer (LPCa) patients in comparison with aged-matched healthy controls. Methods LPCa …